Business Standard

Wednesday, December 25, 2024 | 06:38 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Cadila to make India's first indigenous antibody test kit: Health Minister

The anti-SARS-Cov-2 human lgG ELISA kit has the advantage of testing 90 samples together in a single run of 2.5 hours

The government is now trying to understand how long it will take before the drug’s production can start in India
Premium

So far, ELISA kits were being largely imported with focus of indigenous manufacturing largely towards real-time polymerase chain reaction

Vinay Umarji Ahmedabad
Cadila Healthcare Ltd. (Zydus Cadila) is set to make India's first indigenously developed anti-SARS-Cov-2 human IgG ELISA test kit for antibody detection of Covid-19 (novel coronavirus), Union health minister Harsh Vardhan said in a tweet on Sunday.
National Institute of Virology, Pune has successfully developed the 1st indigenous anti-SARS-CoV-2 human IgG ELISA test kit for antibody detection of #COVID19 .

This robust test will play a critical role in surveillance of proportion of population exposed to #SARSCoV2 infection pic.twitter.com/pEJdM6MOX6
— Dr Harsh Vardhan (@drharshvardhan) May 10, 2020
Developed

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in